Three-dimensional organoid model for acquired drug resistance in non-small cell lung cancer

被引：0
|
作者：
Shukla, Navika D. [1 ]
Salahudeen, Ameen A. [1 ]
Padda, Sukhmani K. [1 ]
Neal, Joel W. [1 ]
Wakelee, Heather A. [1 ]
Kuo, Calvin J. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
CLINICAL CANCER RESEARCH | 2018年 / 24卷 / 17期
关键词：
D O I：
10.1158/1557-3265.AACRIASLC18-B30
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B30
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer
    Chhouri, Houssein
    Alexandre, David
    Grumolato, Luca
    CANCERS, 2023, 15 (02)
  • [32] Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer
    J. Gao
    H.-R. Li
    C. Jin
    J.-H. Jiang
    J.-Y. Ding
    Clinical and Translational Oncology, 2019, 21 : 1287 - 1301
  • [33] REBIOPSY IN NON-SMALL CELL LUNG CANCER PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKI
    Yamauchi, Hiroyoshi
    Nakayama, Masayuki
    Yamamoto, Shinichi
    Saito, Tatsuya
    Okuyama, Akiko
    Mato, Naoko
    Yamasawa, Hideaki
    Suzuki, Takuji
    Bando, Masashi
    Hagiwara, Koichi
    RESPIROLOGY, 2017, 22 : 242 - 242
  • [34] Advances in the management of acquired resistance to EGFR-TKI in non-small cell lung cancer
    Fei Zhou
    Caicun Zhou
    Oncology and Translational Medicine, 2015, 1 (01) : 20 - 25
  • [35] The establishment of patient-derived organoid models and drug response of resectable non-small cell lung cancer
    Chen, J-H.
    Chu, X-P.
    Zhang, J-T.
    Nie, Q.
    Su, J.
    Yan, H-H.
    Zheng, H-P.
    Chen, X.
    Song, M-M.
    Chang, L-P.
    Li, P-S.
    Guan, Y-F.
    Wu, Y-L.
    Zhong, W-Z.
    ANNALS OF ONCOLOGY, 2019, 30
  • [36] PRMT5 mediates cancer stemness and acquired drug resistance in EGFR-mutant non-small cell lung cancer
    Abe, Yoshinori
    Tanaka, Nobuyuki
    CANCER SCIENCE, 2021, 112 : 295 - 295
  • [37] Drug Resistance to EGFR Tyrosine Kinase Inhibitors for Non-small Cell Lung Cancer
    Shien, Kazuhiko
    Yamamoto, Hiromasa
    Soh, Junichi
    Miyoshi, Shinichiro
    Toyooka, Shinichi
    ACTA MEDICA OKAYAMA, 2014, 68 (04) : 191 - 200
  • [38] Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance
    Wu, Jiajia
    Lin, Zhenghong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [39] Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer
    Zhou, Kexun
    Li, Shuo
    Zhao, Yi
    Cheng, Ke
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [40] GefitinibDevelopment of drug resistance in non-small cell lung cancer adenocarcinoma: case report
    Reactions Weekly, 2017, 1668 (1) : 192 - 192
12345